GEN Exclusives

More »

GEN News Highlights

More »
Mar 3, 2011

Charles River to Distribute Pfizer Research Models

Charles River to Distribute Pfizer Research Models

The models are in therapeutic areas that include neuroscience, diabetes and cardiovascular disease. [© ktsdesign - Fotolia.com]

  • Charles River Laboratories inked an agreement with Pfizer to market and distribute to researchers worldwide precompetitive, transgenic research models. The Pfizer-developed models are in therapeutic areas that include neuroscience, diabetes, and cardiovascular disease.

    The models will be used in research to target specific disease states and genetic markers, says Dr. Iva Morse, corporate vp, global research model services at Charles River.

    Rick Connell, Pfizer’s vp and worldwide head of external research solutions center of excellence, says the agreement “aligns with Pfizer’s strategy to externalize our precompetitive tools and assets to a broader community of scientists outside of Pfizer’s walls.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?